MedCity News
SEPTEMBER 22, 2024
During a panel discussion at MedCity News’ INVEST Digital Health conference in Dallas, three venture capital investors shared some of the questions they ask when getting pitched by digital health startups. The post 3 Questions VCs Ask When Getting Pitched By Startups appeared first on MedCity News.
pharmaphorum
SEPTEMBER 22, 2024
FTC lawsuit accuses top three PBMs of using a perverse drug rebate system to artificially inflate the price of insulin products and their profits
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
SEPTEMBER 22, 2024
The reintroduction of the “Improving Seniors’ Timely Access to Care Act” marks a critical step toward modernizing the prior authorization process within Medicare Advantage plans. So, what does this mean for patients and providers moving forward? The post Navigating the Government’s Medicare Advantage Prior Authorization Changes appeared first on MedCity News.
Pharmacy Times
SEPTEMBER 22, 2024
The researchers estimate that pregnancy losses because of malaria and parasitemia risk before conception was reduced by 65% to 86%.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
MedCity News
SEPTEMBER 22, 2024
MDMA-assisted therapy (MDMA-AT) for PTSD sparked debate, primarily focused on concerns of safety and efficacy. But no matter how novel a treatment may be, if it is inaccessible to the millions of people who need it, its relevance becomes insignificant. The post Breaking Barriers: Why Accessibility Matters in PTSD Treatment Beyond MDMA appeared first on MedCity News.
MedCity News
SEPTEMBER 22, 2024
Insilico Medicine’s idiopathic pulmonary fibrosis drug led to dose-dependent improvement in lung function in a mid-stage study. Meanwhile, Pliant Therapeutics and PureTech Health are also making Phase 2 progress while Boehringer Ingelheim is planning regulatory submission supported by its IPF drug’s Phase 3 data. The post AI-Designed Insilico Drug Flashes Signs of Efficacy in Lung Disease, But Rivals Are Still Ahead appeared first on MedCity News.
MedCity News
SEPTEMBER 22, 2024
Dr. Cunningham weighed in on a variety of subjects, including elements of technology and virtual care that burden primary care physicians, as well as technologies that are suitable for remote monitoring of older patients. The post 7 Takeaways From a Fireside Chat with Providence’s Chief of Virtual Care appeared first on MedCity News.
Expert insights. Personalized for you.
113 
Let's personalize your content